ArticleInternational journal of molecular sciences2022

Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma.

Sumit Siddharth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.